Some GLP-1 medications have demonstrated cardiovascular benefits in clinical trials (such as LEADER for liraglutide, SUSTAIN-6 for semaglutide, and REWIND for dulaglutide), and discontinuation may result in loss of these protective effects
Tissue-specific peptide processing occurs through prohormone convertases that produce glucagon in the pancreas and GLP-1 and GLP-2 in the intestine 2
Its only been shown to affect the amount of birth control pill absorbed by your stomach, which could make it work less well
For a triple-receptor agonist that targets GLP-1 , GIP, and glucagon receptors simultaneously, the neurological ripple effects are still being studied, still being understood
For six subjects, baseline GSH peaks were undetectable
Glycogen synthesis and catabolism mainly occur in the liver, which is the primary target organ for insulin action